Modus Therapeutics Holding AB (OSTO:MODTX) FFO


OSTO:MODTX Modus Therapeutics Holding AB OSTO:MODTX
30 GF Score
Price kr0.37
! 1 Warning Sign
View Full Analysis

What is Modus Therapeutics Holding AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:MODTX
30GF Score
Modus Therapeutics Holding AB OSTO:MODTX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modus Therapeutics Holding AB Business Description

Address Olof Palmes gata 29 IV, Stockholm, SWE, 111 22
Modus Therapeutics Holding AB is a Swedish biotechnology company developing its patented polysaccharide, sevuparin, as a potential treatment for unmet medical needs. Its research focuses on conditions involving severe systemic inflammation, including sepsis and septic shock, severe malaria, and other related disorders, as well as anemia associated with chronic inflammatory conditions such as kidney disease.
30GF Score

Get the complete analysis for OSTO:MODTX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.37
Price